Article
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.
AIDS (London, England) - 14 Apr 2000
Puig T, Pérez-Olmeda M, Rubio A, Ruiz L, Briones C, Franco J M, Gómez-Cano M, Stuyver L, Zamora L, Alvarez C, Leal M, Clotet B, Soriano V
Abstract excerpt
OBJECTIVE: To examine the prevalence of resistance mutations to nucleoside reverse transcriptase inhibitors (NRTI) and protease inhibitors (PI) in a representative HIV-1 population in Spain. METHODS: A cross-sectional study was conducted including 601 HIV-infected patients who attended 20 Spanish hospitals in June 1998. Drug resistant mutations were examined using hybridization line probe assays (LiPA). The 6 bp...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.